Browsing Oncology by Author "Bulumulle, Anushi"
-
Association of Extended Dosing Intervals or Delays in Pembrolizumab-Based Regimens With Survival Outcomes in Advanced Non-small-cell Lung Cancer
Bulumulle, Anushi; Brody, Heather; Macherla, Shravanti; Walker, Paul R.; Sehgal, Kartik; Gill, Ritu R.; Qilleri, Aleksandra; McDonald, Danielle C.; Cherry, Cynthia R.; Shea, Meghan; Huberman, Mark S.; VanderLaan, Paul A.; Weiss, Glen J.; Costa, Daniel B.; Rangachari, Deepa (2021) -
Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma
Muzaffar, Mahvish; Navaid, Musharraf; Bulumulle, Anushi; Fessas, Petros; Naeem, Muntaha; Pinterb, Matthias; Marron, Thomas U.; Szafron, David; Balcar, Lorenz; Saeed, Anwaar; Jun, Tomi; Dharmapuri, Sirish; Gampa, Anuhya; Wang, Yinghong; Khan, Uqba; Lee, Pei-Chang; Yu, Bo; Paul, Sonal; Nimkar, Neil; Bettinger, Dominik; Hildebrand, Hannah; Abugabal, Yehia I.; Pressiani, Tiziana; Personeni, Nicola; Nishida, Naoshi; Kudo, Masatoshi; Kaseb, Ahmed; Huang, Yi-Hsiang; Ang, Celina; Pillai, Anjana; Rimassa, Lorenza; Naqash, Abdul Rafeh; Sharon, Elad; Cortellini, Alessio; Pinato, David J. (2021-10-08) -
Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma
Muzaffar, Mahvish; Navaid, Musharraf; Bulumulle, Anushi; Fessas, Petros; Naeem, Muntaha; Pinter, Matthias; Marron, Thomas U.; Szafron, David (2021-10-08) -
Patterns and Outcomes of Subsequent Therapy After Immune Checkpoint Inhibitor Discontinuation in HCC
Muzaffar, Mahvish; Bulumulle, Anushi; Sharma, Rohini (2022)